An estimated 7.4 million Americans age 65 and older are living with Alzheimer’s disease in 2026, a number that could reach 13.8 million by 2060.¹ Nearly 1 million more Americans are living with multiple sclerosis (MS).² For neuroscience service lines, these figures mean sustained demand across diagnosis, treatment and long-term monitoring, with imaging at the center of each.